Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

11 trials with published results (14%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.9%

3 terminated out of 76 trials

Success Rate

92.5%

+6.0% vs benchmark

Late-Stage Pipeline

14%

11 trials in Phase 3/4

Results Transparency

30%

11 of 37 completed with results

Key Signals

11 with results93% success

Data Visualizations

Phase Distribution

59Total
Not Applicable (44)
Early P 1 (1)
P 2 (3)
P 3 (4)
P 4 (7)

Trial Status

Completed37
Unknown12
Recruiting11
Withdrawn6
Not Yet Recruiting4
Terminated3

Trial Success Rate

92.5%

Benchmark: 86.5%

Based on 37 completed trials

Clinical Trials (76)

Showing 20 of 20 trials
NCT07379775RecruitingPrimary

Evaluation of the Reliability of AAR as an Independent Tool for Surgical Indication in Nasal Obstruction

NCT07531810Recruiting

Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

NCT07626437Phase 3Recruiting

Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults

NCT07620522Not Yet RecruitingPrimary

Observational Study of RHINOSEDAL in Acute Nasal Obstruction

NCT05920330Not ApplicableRecruitingPrimary

Nasal Obstruction and Olfactory Losses

NCT07599826Not ApplicableNot Yet Recruiting

Active vs. Passive VR During Office-based ENT Procedures

NCT07323888Not ApplicableActive Not RecruitingPrimary

Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis

NCT07568548Not ApplicableNot Yet Recruiting

Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic Nasopharyngitis

NCT04194216Phase 3Enrolling By InvitationPrimary

Antibiotic Prophylaxis in Rhinoplasty

NCT07168148Phase 2TerminatedPrimary

Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants

NCT06438185Not ApplicableCompleted

Efficacy And Safety of An IRE System For Treatment of Inferior Turbinate Hypertrophy

NCT07050992Not ApplicableActive Not Recruiting

Laser Posterior Nasal Nerve Neurolysis

NCT06580210Recruiting

Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction

NCT04150783Completed

Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes

NCT06483204Phase 4Withdrawn

Steroids for Rhinoplasty: Pain, Nausea, Edema and Ecchymosis

NCT07215013Not ApplicableNot Yet Recruiting

Acoustic Resonance Therapy for Treating Empty Nose Syndrome

NCT05494346Not ApplicableRecruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT06830109Phase 2RecruitingPrimary

Nasal Obstruction With Oxymetazoline and Corticosteroids

NCT05099263Not ApplicableCompletedPrimary

The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)

NCT07140250Not ApplicableCompleted

Using ChatGPT to Help Guide Treatment for Sinus and Nasal Problems

Scroll to load more

Research Network

Activity Timeline